Author

Simon Bajew

Barcelona Institute of Science and TechnologyORCID 0000-0003-1643-1035Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:gene regulatory network inference· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:differential expression· 1 Research Focus:GWAS / association mapping· 1 Organism:human· 1 Organism:mouse· 1 Organism:multiple species· 1

Frequent Co-Authors

Manuel IrimiaiD· 2 shared Sophie BonnaliD· 2 shared Amaya López-PascualiD· 1 shared Goutham AtlaiD· 1 shared Jonàs Juan‐MateuiD· 1 shared Jorge P. FerreriD· 1 shared Juan ValcárceliD· 1 shared L. IñigueziD· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Manuel IrimiaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologyNature Structural & Molecular BiologyPeer-reviewedAug 7, 2025

Core splicing architecture and early spliceosomal recognition determine microexon sensitivity to SRRM3/4

Sophie Bonnal, Simon Bajew, Rosa Martinez-Corral, Manuel Irimia

The paper identifies core splicing architecture and length constraints as factors determining microexon sensitivity to SRRM3/4 across vertebrates.

5 citations

multiple speciesstatistical model

𝕏 PostBluesky

Molecular BiologybioRxivPreprintApr 2, 2022

Control of pancreatic islet function and glucose homeostasis by a novel microexon program misregulated in type 2 diabetes

Jonàs Juan‐Mateu, Simon Bajew, Marta Miret-Cuesta…·Manuel Irimia

The paper identifies a microexon program in pancreatic islets regulated by SRRM3, which affects insulin secretion and is linked to type 2 diabetes risk.

DOI 10.1101/2022.04.02.486809

𝕏 PostBluesky